Lockheed Martin Investment Management Co. cut its holdings in shares of Sempra (NYSE:SRE – Free Report) by 9.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,600 shares of the utilities provider’s stock after selling 4,200 shares during the period. […]
Sempra (NYSE:SRE – Get Free Report) had its price objective dropped by equities research analysts at LADENBURG THALM/SH SH from $81.50 to $79.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the utilities provider’s stock. LADENBURG THALM/SH SH’s price target would suggest a potential upside of 4.79% […]
Boston Family Office LLC lowered its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 1.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,023 shares of the biopharmaceutical company’s stock after selling 1,159 shares during the period. Boston Family Office […]
Fiduciary Trust Co decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 13.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 370,517 shares of the biopharmaceutical company’s stock after selling 55,639 shares during the quarter. Fiduciary Trust Co’s […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Michael S. Brown sold 1,172 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $974.86, for a total value of $1,142,535.92. Following the completion of the sale, the director now directly owns […]